Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Achieves Notable Growth, Investments in 2017

Global technology and value-added solutions group Net Element (NASDAQ: NETE) demonstrated impressive gains in 2017, such as reaching the company’s strongest balance sheet and securing a $7.55 million investment. An article discussing the company reads: “In 2017, the company received a $7.55 million institutional investment, supporting continued organic growth and ensuring full scalability of its platform, as well as blockchain-focused developments. Deloitte’s 2017 Technology Fast 500™ ranked Net Element as one of the fastest-growing companies in North America. The year before, 2016, South Florida Business Journal ranked Net Element as one of the fastest-growing technology companies. When Hurricane Irma hit, the company was ready and able to support affected Florida SMB merchants with free mobile point-of-sale credit card readers. Net Element works to provide virtually seamless payment solutions and powerful problem-solving expertise to the small to medium enterprises it serves. The $7.55 million investment has put the company in position to continue achieving organic growth as it moves forward with innovative blockchain developments.”

To view the full article, visit http://ibn.fm/vM0Hb

About Net Element

Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the US and selected emerging markets. In the US it aims to grow transactional revenue by innovating SME productivity services such as its cloud based, restaurant and retail point-of-sale solution Aptito. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions such as UAE, Kazakhstan, Kyrgyzstan and Azerbaijan where initiatives have been recently launched. Net Element was named in 2016 by South Florida Business Journal as one of the fastest growing technology companies. Further information is available at www.NetElement.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Net Element Inc. NETE | Leave a comment

Pivot Pharmaceuticals Inc. (PVOTF) Provides Update Covering Recent Achievements and Activities

  • Update highlights proposed acquisitions, product development and growing IP portfolio
  • Three new patent filings join established global rights to other patented technologies
  • Innovative transdermal delivery technology increases bioavailability of cannabinoids
  • Global cannabis market projected to reach $31.4 billion by 2021

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) has provided investors an update covering a number of recent achievements and ongoing activities, including the company’s proposed acquisitions of ERS Holdings, LLC and Thrudermic, LLC; its ongoing product development efforts; its growing IP portfolio; its termination of a previously announced standstill agreement; out-licensing of its IP; and its engagement of an established European distribution partner (http://ibn.fm/GZfrU). In a news release, Dr. Patrick Frankham, CEO of Pivot, stated, “We are overwhelmed by interested companies who now understand that derivatives and superior formulations will improve cannabis product experience and healthy outcomes.”

Based in Vancouver, Canada, Pivot Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using proprietary drug delivery platform technologies. By developing and commercializing a number of pharmaceutical-grade formulations for cannabinoid-based consumer health care products, Pivot Pharmaceuticals is positioning itself to capitalize on the impressive growth of the cannabis market. According to market research company Brightfield Group, the marijuana market will experience a CAGR of 60 percent to reach $31.4 billion by 2021 (http://ibn.fm/8ePj2).

As part of its overall growth strategy, Pivot Pharmaceuticals recently filed three provisional patents for cannabinoid-based product delivery with the U.S. Patent and Trademark Office, according to a company press release (http://ibn.fm/tcV0W) issued on February 1, 2018. Its three patents cover:

  • Transdermal nanotechnology delivery of cannabis using patches and creams
  • Mucus topical cannabis delivery through buccal, nasal, vaginal and anal areas using a gel, mouthwash or suppository
  • Inhalation delivery of cannabis for topic or systemic applications

These latest provisional patent filings join an established number of global rights to topical, oral, transdermal, food and beverage patented technologies that Pivot has already secured.

A case in point is Pivot’s recent acquisition of the BiPhasix™ Transdermal Drug Delivery technology for the delivery of cannabinoids. Oral delivery of cannabinoids can produce inconsistent absorption efficiencies and unfavorable side effects, while topical delivery technologies often suffer from weak formulation issues. By contrast, transdermal delivery has greater potential to produce a more favorable outcome without the negative side effects and absorption issues. Another benefit of transdermal delivery is that it enables patients to apply medication over a prolonged period with fewer side effects than with other methods of delivery. The BiPhasix™ delivery system, thoroughly tested in clinical trials approved by the FDA and EMA, was demonstrated to enhance the bioavailability of drugs and to improve clinical outcomes.

Pivot Pharmaceuticals also created subsidiary Pivot Green Stream Health Solutions Inc. to focus on improving the bioavailability of cannabinoid-based pharmaceuticals. Pivot Green Stream will develop natural cannabinoid-based health products that qualify for the Natural Health Product (NHP) designation conferred by Health Canada.

In addition, Pivot has acquired the global rights from Solmic GmbH for the development and commercialization of the Solmic Solubilization Technology Platform. This formulation technology provides significantly higher bioavailability of active ingredients while masking unpleasant tastes and smells. This oral delivery platform greatly increases uptake of fat-soluble ingredients from the gut into the blood system, resulting in increased bioavailability.

The company has several products in its development pipeline which target cancer supportive care, pain and inflammation, dermatology and eye disease. They include PGS-N005, a cannabinoid-based topical cream to treat female sexual dysfunction. This formulation will treat hypoactive sexual desire disorder, aimed specifically at peri-menopausal, menopausal and post-menopausal women with a decline in sexual desire and response. It is estimated that up to 63 percent of women in the United States may be affected by this disorder, with the female sexual dysfunction market estimated to exceed $4 billion.

Pivot Pharmaceuticals has a seasoned management team with extensive clinical, product development, commercial and financial experience. The company has positioned itself to be a crucial vertical in the cannabis industry, with a focus on biotechnological development. As part of its business strategy, Pivot works with licensed producers (LPs) and licensed dealers (LDs) to bring new therapies to the market.

For more information, visit the company’s website at www.PivotPharma.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

Earth Science Tech, Inc. (ETST) Launches High Grade Full Spectrum Cannabinoid Products

  • ETST intends to make 2018 its breakout year, seeks uplisting to the OTCQB Venture Market
  • Company manufactures using European CO2 extraction process with organically grown, unfiltered industrial hemp
  • ETST engages a new distributor to market revamped product line to major retailers, also adds several new members to its executive team

On February 13, Earth Science Tech, Inc. (OTC: ETST) officially launched its High Grade Full Spectrum Cannabinoids products and a corresponding marketing strategy, as the company detailed in a recent news release (http://ibn.fm/Q4pQN). Additionally, it signed a distribution agreement with Mr. Checkout to market its revamped product line to major retailers and stores, such as Walmart, Target and Walgreens (http://ibn.fm/BgSyv).

The revamped line consists of industrial hemp product formulated as a cannabinoid complex, which is naturally occurring in the industrial hemp plant and is rich in terpenes and saponins. The company’s products are mixed, bottled and packaged in the U.S., and reorders are currently being accepted online. The line appears in modern and edgy packaging.

Based in Florida, ETST markets high-purity, high-grade hemp cannabidiol (CBD) oil. It is 100 percent natural and organic. The company has three wholly-owned subsidiaries: Earth Science Pharmaceutical markets low-cost, non-invasive medical devices for the detection of sexually transmitted diseases (STDs); Cannabis Therapeutics is an emerging biotechnology company; and KannaBidioiD focuses on the recreational space with its hemp and Kanna blends.

ETST recently strengthened its core executive team (http://ibn.fm/kTUuA) through the addition of Jill Buzan as chief sales officer, Wendell Hecker as chief financial officer and Gabriel Aviles as chief learning officer. The company expects the moves to foster bottom line growth in 2018.

In a news release, Nickolas S. Tabraue, COO and president of ETST, said, “Between appointing a new Chief Sales Officer, launching revamped industrial hemp products with fresh branding and marketing strategies, and our new distributor, Mr. Checkout, we are on track for a record-setting revenue month.” He added that the company intends to make 2018 its breakout year, for which it is laying a strong foundation in the first quarter.

The company also announced that it has completed the paperwork for its uplisting to the OTCQB Venture Market later this year.

For more information, visit the company’s website at www.EarthScienceTech.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Earth Science Tech, Inc. ETST | Leave a comment

MissionIRNewsBreaks – Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRA: 6F6) (WKN: A2AKL8) Intends to Acquire V2 Games; Shares Surge

Shares of Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) are up 8.7% after the company this morning said it intends to acquire 100% of all issued and outstanding shares of V2 Games Inc. at a purchase prices of $2,000,000 CAD, subject to all requisite regulatory approvals. V2 Games is an established mobile games studio with an impressive portfolio of highly-rated entries on the Apple Store listings. In accordance to the definitive share purchase agreement to be executed between the company and the shareholder(s) of V2 Games, the purchase price will be paid by the company through the issuance of 1,030,928 common shares to the shareholder(s) of V2 Games at a deemed issue price of $1.94 per consideration share. The consideration shares will be subject to resale restrictions, permitting 8% of the shares to be eligible to be free trading four months from the date of issuance and a further 8% every three months thereafter until the final balance of shares is eligible to be free-trading. “Given the full and total philosophical alignment between our companies, we are of course excited and proud to announce the acquisition of V2 Games, a leading mobile games developer based in Vancouver, Canada,” said Victory Square CEO Shafin Diamond Tejani stated in the news release.

To view the full press release, visit http://ibn.fm/aTP0j

About Victory Square Technologies Inc.

Victory Square Technologies is a blockchain-focused venture builder that funds and empowers entrepreneurs to implement innovative blockchain solutions. Victory Square portfolio companies are disrupting every sector of the global economy including Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. Victory Square has a proven process for identifying game-changing entrepreneurs and providing them with the partners, mentorship and support necessary to accelerate their growth and help them scale globally. For more information, please visit www.VictorySquare.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Victory Square Technologies Inc. VSQTF | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Co-Marketing, Distribution Agreement with ISS, Inc.

Pressure BioSciences (OTCQB: PBIO) this morning said it has entered a two-year, global co-marketing and distribution agreement with ISS, Inc. The companies intend to combine the ISS high pressure optical cell with Pressure BioSciences’ automated high pressure instrument resulting in an exceptional analytical system with the potential to substantially improve biopharmaceutical drug discovery and development. High pressure optical spectroscopy is gaining popularity among scientists worldwide for its unique and effective way to look at molecular interactions. The new ISS/PBI instrument system is set to be unveiled at the annual Biophysical Society Meeting (“BPS”) which begins on February 17th in San Francisco, CA. “Interfacing the PBI HUB 440/880 pressure generators with the ISS high pressure optical cell system will allow scientists to visualize and measure pressure effects on molecular interactions and protein conformation as the reactions are taking place in the optical cell – in real time. This novel capability should help scientists better understand how proteins function and interact with other biomolecules, which is critically important in the development of better, more effective diagnostics and pharmaceuticals,” Pressure BioSciences VP of R&D, Dr. Alexander Lazarev stated in the news release.

To view the full press release, visit http://ibn.fm/gMLs9

About Pressure BioSciences Inc.

Pressure BioSciences Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of PBI’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

KBS Fashion Group Limited (NASDAQ: KBSF) Names Chairman Keyan Yan as New CEO and President

  • KBSF, through subsidiaries, operates more than 50 stores in China and also sells its line to multi-brand retailers
  • Company is vertically-integrated – designing, marketing, manufacturing and selling its line of men’s footwear, apparel and accessories while targeting style-conscious urban males
  • China-based company offers line of menswear that is practical, yet modern and stylish, enabling the client to express his personality through his clothes

KBS Fashion Group Limited (NASDAQ: KBSF) has named Keyan Yan its new CEO and president (http://ibn.fm/FLC2N). He continues to serve as board chairman of the company. The size of the board was reduced to seven.

Xiaowen Zheng tendered his resignation as CEO, president and director of the company, but KBSF said that this was not a result of any disagreement or dispute with the company or its management regarding any matters relating to operations, policies or practices.

China-based KBSF is a fully-integrated casual menswear company that, through its subsidiaries, designs, manufactures, markets and sells its own line of menswear. It targets urban males in the 20-40 age range with apparel, footwear and accessories. KBSF operates over 50 KBS stores and sells via a number of multi-brand stores.

The company is focused on the practical and “keep best style” concept in fashion design. It offers clothes in modern and colorful contemporary styles. The company says that the fashion offered by KBSF is designed for the stylish man who wishes to show his personality through his clothes.

For more information, visit the company’s website at www.KBSFashion.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Small Cap News | Leave a comment

Cryptocurrencies Could Hit $1 Trillion in Value in 2018, with Bitcoin Reaching $50,000

  • Jamie Burke, CEO of Outlier Ventures, predicts a bull run first, then a ‘crypto winter’ during which the market will become focused on proper market fundamentals; he sees cryptocurrencies achieving $1 trillion in value in 2018
  • Thomas Glucksmann of Gatecoin sees bitcoin pushing $50,000 by December
  • Digital coins may also gain in value, but beware of future market bubbles, says Mick Sherman, CEO of Hercules Tech

Cryptocurrencies could reach levels of up to $1 trillion this year, experts say, with bitcoin hitting up to $50,000 (http://ibn.fm/uz34o). Despite volatile financial markets, several experts predict that a bull run market could materialize later this year, as noted in a piece published by CNBC. In fact, some say that digital coins, or tokens, could appreciate as well.

Jamie Burke, CEO of Outlier Ventures, told CNBC that cryptocurrencies could pass the $1 trillion mark in value in a bull run market this year. Burke founded this venture capital firm, which focuses on blockchain investments.

“We believe after February the market will likely go on a bull run comparative if not greater than last year potentially reaching the trillion-dollar mark before a proper crypto winter sets in where the market becomes more focused on proper market fundamentals,” he said in an email to CNBC.

Thomas Glucksmann, head of APAC business development with cryptocurrency exchange Gatecoin, added, “There is no reason why we couldn’t see bitcoin pushing $50,000 by December.” He also referenced a bitcoin lightning network that could increase the speed of bitcoin transactions. He said that it’s only a matter of time before an exchange-traded fund backed by cryptocurrency.

“Increasing regulatory recognition of cryptocurrency exchanges, the entrance of institutional capital and major technology developments will contribute to the market’s rebound and push cryptocurrency prices to all new highs this year,” Glucksmann wrote.

Digital coins, or utility tokens, may have no immediate utility value, but they may appreciate as they can be used to build new blockchain applications. Mick Sherman, co-founder and CEO of Hercules Tech, told CNBC, “Utility tokens and assets with a working platform and clear-cut reason for requiring both a blockchain and their own token, are more likely to appreciate in value this year. Some of these crypto assets will not be used for years, meaning they have no utility value.”

Sherman also cautioned investors that, despite future growth, there could be more bubbles ahead for blockchain projects.

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Small Cap News | Leave a comment

MissionIRNewsBreaks – Earth Science Tech, Inc. (ETST) Secures Laboratory Partner for Clinical Studies of MSN-2 Medical Device

Science-based biotechnology company Earth Science Tech, Inc. (OTC: ETST) recently signed an agreement with a private laboratory for clinical studies related to its MSN-2 medical device. “We are on the cusp of making tremendous progress in our clinical trial efforts,” Dr. Michel Aubé, CEO and CSO of ETST, stated in a news release. An article discussing the agreement reads: “ETST now has the laboratory partner needed to support the company’s research and development efforts, along with the commercialization of its MSN-2 medical device, which has been specifically developed to support women’s health and the related molecular diagnostics to which women desperately need access, Aubé said.”

To view the full article, visit http://ibn.fm/5yENN

About Earth Science Tech, Inc.

Earth Science Tech has among the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the superior supercritical CO2 liquid extraction, the company’s CBD Oil is 100% natural and organic. Earth Science Tech’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, validates the company’s position as a leading nutritional and dietary supplement brand for High Grade Hemp CBD Oil. For more information, visit the company’s website at www.EarthScienceTech.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Earth Science Tech, Inc. ETST, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (PVOTF) Issues Corporate Update

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) this morning issued a corporate update detailing its recent activity. Per the release, the company has had a “very active” start to the current calendar year, with its management team working to build a “differentiated” company in the cannabis sector by focusing on improving the cannabis consumer experience with scientifically-derived products. Pivot’s notable corporate highlights include its proposed acquisitions of ERS Holdings, LLC and Thrudermic, LLC; its ongoing product development efforts; its growing IP portfolio; its termination of a previously announced standstill agreement; out-licensing of its IP; and its engagement of an established European distribution partner. “I am extremely proud of the entire Pivot team as we continue to execute our business plan,” Dr. Patrick Frankham, CEO of Pivot, stated in the news release. “We are overwhelmed by interested companies who now understand that derivatives and superior formulations will improve cannabis product experience and healthy outcomes. We continue to believe that sustainable cannabis companies will have pipelines of products to meet the needs of consumers seeking wellness and healthy lifestyles.”

To view the full press release, visit http://ibn.fm/dy28g

About Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that provide novel treatments for unmet healthcare needs. Pivot Pharmaceutical’s subsidiary, Pivot Green Stream Health Solutions Inc., will focus on improving the bioavailability of cannabinoid-based pharmaceuticals. Pivot Green Stream is tasked with developing several natural health products containing cannabinoids that can receive a Health Canada Natural Health Product designation. For more information, visit www.PivotPharma.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Exploring Lithium Extraction Potential of Arkansas Brine Fields

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) is exploring the potential of extracting battery-grade lithium for the modern tech fuel market from brine fields in the large production-ready Smackover Formation that stretches across Southern Arkansas and neighboring states. The demand for lithium is expected to skyrocket over the next eight years, particularly in conjunction with growing demand for electric vehicles. An article discussing this reads: “Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) actively seeks to reduce political, permitting and technology risks, all while positioning itself as a leader in the production of lithium. The company works to eliminate exploration and development risks by focusing on existing brine fields and partnering with U.S. chemical processing companies. By focusing on U.S.-based assets, Standard reduces political and geographical risks, working within jurisdictions that already understand how to permit and approve brine extraction and processing at large industrial scales.”

To view the full press release, visit http://ibn.fm/oLEia

About Standard Lithium Ltd.

Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The Company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The Company is also commencing resource evaluation on up to 33,000 acres of brine leases located in the Smackover Formation. Please visit the Company’s website at http://nnw.fm/standardlithium

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Standard Lithium Ltd. STLHF | Leave a comment